Considering the UV exposure of normal people in everyday life, the presence and quantity of UVA radiation are rather high.
exposure, high levels of ROS can be detected in cells. One way how UVA facilitates ROS is mediated by photosensitizers. When cells are hit by UVA radiation, ubiquitous molecules such as nicotinamide adenine dinucleotide (NADH) can act as photosensitizers, absorbing the energy of UVA and transferring it to oxygen molecules to generate ROS in cellular compartments. [15, 16] These ROS are capable to cause oxidative damage to proteins or DNA. One prominent ROS-induced DNA damage is an oxidized guanosine, the 8-oxoguanosine, which can block transcription. [17] This damage and many other oxidative lesions within the genome are repaired by the base excision repair pathway (BER). In BER, the damaged base is excised from its ribose by a repair enzyme with glycosylase activity, and consecutively, ribose is removed and finally the single nucleotide gap in DNA is refilled and ligated to restore DNA integrity (in short-patch BER). Sometimes several nucleosides adjacent to the damaged nucleotide are also removed (in long-patch BER), and the gap of several nucleotides in DNA is then refilled and ligated to restore DNA integrity. When 8-oxoguanosine is not repaired by BER, it can give rise to error-prone replication (predominantly GC to TA transversions), [18] leaving a more or less characteristic mutation pattern (UVA fingerprint mutations). These UVA fingerprint mutations have been found in non-melanoma skin cancer, [19] and their presence is discussed in melanoma. [20] [21] [22] While studies have shown that the carcinogenic potential of UVB can also be relevant to melanoma, [23] the contribution of UVA radiation to the development of melanoma was contested as initial studies failed to detect the ability of UVA to induce melanoma. Early studies showed that UVA irradiation was capable to induce melanoma in the opossum but not in Xiphophorus hybrid fish. [24] In early studies in transgenic mice on an albino background, one neonatal dose of UVA irradiation could not significantly induce melanotic tumors. [25] [26] [27] But surprisingly when albino background in transgenic mice was exchanged with a pigmented background, one single neonatal UVA treatment [28] is able to induce melanomas. With this study, the potential of UVA irradiation to induce melanoma in mice was accepted. In humans, epidemiological data of patients which used tanning beds with high-dose UVA irradiation showed high levels of melanoma. [29, 30] It has to be mentioned that in patients melanoma also occur on usually sun-protected body sites [31] . But these observations just underline the obvious fact that UV radiation is likely not the sole cause of all melanoma, as many other factors such as genetic susceptibility or carcinogenic events different from UV can also contribute to the formation of melanoma. More recent epidemiological data point to a connection between sunburn and melanoma in sunsensitive patients. [32] Upon UVA-induced ROS formation, the so-called stress signalling network is activated, which also plays an important role in apoptosis.
In this complex network, epidermal growth factor receptor (EGFR) signalling and mitogen-activated protein kinase (MAPK) are activated to coordinate the cellular response, like special transcription programmes with the activation of ROS-detoxifying enzymes, but also important metabolic enzymes. [33, 34] To cope with UVA-induced damage, one could assume that the cell also changes its metabolism, particularly glucose metabolism to provide energy and metabolites for those repair processes. involving respiration. [36] [37] [38] This enhanced consumption of glucose, even in the presence of oxygen, was observed in many different tumors and was later termed Warburg effect. Also melanoma cells consume more glucose and produce more lactate compared to melanocytes. [39] One prominent explanation of this metabolic preference is the need of cellular building bricks for proliferating cells. Instead of complete oxidation of glucose to CO 2 involving mitochondrial respiration, pyruvate can be used to form amino acids, fatty acids and riboses via the pentose phosphate pathway. [35] How exactly UVA radiation can change the metabolism within the complex environment of the skin is not yet fully understood.
| ENHAN CED G LUCOS E ME TABOLIS M IN PROLIFER ATING CELL S AND THE WARBURG EFFEC T
There are a few studies investigating changes in specific metabolites with focus on signalling (arachidonic acid metabolism, urocanic acid), [40, 41] but large metabolic changes in glucose metabolism have only recently been described by our group where it was shown that UVA irradiation increases glucose consumption and the production of lactic acid in melanoma cells. [42] Furthermore, in this setting the pentose phosphate pathway is also upregulated by UVA radiation.
At least some of these UVA-induced changes in glucose metabolism are connected to the UVA-induced ROS formation as the addition of ROS quenchers decreases the UVA-enhanced glucose metabolism.
UVA-enhanced glucose metabolism is accompanied by an increased activation of the Akt kinase also regulating metabolism. Interestingly, UVA-induced glucose consumption, lactic acid production and the enhanced pentose phosphate pathway persisted 5 days after the cessation of UVA irradiation, indicating a longer effect of UVA.
Taken together, in the melanoma cell UVA radiation induces damage and changes metabolism towards an increased glucose consumption and lactic acid production. But the important question remains which cellular mechanisms (DNA damage signalling, DNA repair and stress signalling) facilitate these metabolic changes and which benefits the melanoma cells could gain with these metabolic strategies. This will be discussed in the following parts. [44] induced by UVA irradiation with a cumulative dose of 72J/cm 2 [42] and that the damage is repaired only with short- [ [45] [46] [47] [48] In this context, it is important to mention that BER is a basic repair mechanism for the mitochondrial DNA (mtDNA). Investigating the connection between repair and metabolism, Rezvani et al. performed a knockdown of the XPC protein, which is also involved in BER, [49, 50] and observed deficiencies in mitochondrial bioenergetics [47, 51] with decreased mitochondrial ATP levels and increased glycolysis parallel to increased ROS levels and increased nuclear and mitochondrial oxidative DNA damage. The authors propose that the enhanced mutagenesis especially in mtDNA decreases oxidative phosphorylation, which decreases the cellular energy level. To compensate this, the cells activate glycolysis. [47] Considering that there are plenty of copies of mtDNA molecules in a cell, one may expect that much mtDNA damage can be tolerated before deficiencies in oxidative phosphorylation would be observed. But it was reported that relative low levels of mtDNA molecules with mutations can be sufficient to induce metabolic changes. [52, 53] In addition to this, mtDNA mutations can increase the mitochondrial ROS level, which then in turn can induce more mtDNA mutations, leading to a self-amplifying system of accumulated mtDNA mutations. [54] [55] [56] [57] [58] [59] Furthermore, it was shown that UVA irradiation or ROS treatment can cause high levels of mtDNA deletions, [18, 57, [60] [61] [62] [63] and parallel to UVA-induced mtDNA deletions, a decrease in respiration, mitochondrial membrane potential and intracellular ATP level was observed. In this context, one may assume that the cell would upregulate glycolysis to counteract decreased mitochondrial activity and to increase energy levels via glycolysis. Mutations in mitochondrial genes responsible for oxidative phosphorylation in immortalized keratinocytes or cells of head and neck cancer lead to a ROS-mediated accumulation of HIF-1-alpha, [64] which can act as a potent activator of glycolysis. [65] These observations could point to an important role of cellular energy level maintenance during damage processing.
| THE IMMED IATE EFFEC TS
When mitochondrial energy production due to damaging events is decreased, upregulated glycolysis could be a compensation mechanism to maintain cellular energy levels.
Not only ROS-induced DNA damage but also ROS-induced signalling could be relevant for metabolic changes towards enhanced glycolysis or activated pentose phosphate pathway. In a recent publication, ROS-induced mTOR signalling and activation of the transcription factor Myc have been shown to promote the transition from oxidative phosphorylation to aerobic glycolysis with enhanced lactate production during CD4+ T-cell activation. [66] In melanoma pathogenesis, mTOR signalling is important for proliferation [67] and survival, [68, 69] and at least in human epidermal keratinocytes, UVA is capable to activate mTOR signalling. [70] Metabolism may be influenced not only by ROS or direct DNA repair but also by DNA damage signalling. The tumor suppressor protein p53 can be activated upon UVA and it is a central regulator of DNA damage signalling and, although often mutated, it is present in many melanomas [71] and it activates the glycolytic repressor protein TP53-induced glycolysis and apoptosis regulator (TIGAR).
By the involvement of p53 and TIGAR, much of the cellular glucose could be redistributed from glycolysis to the pentose phosphate pathway to decrease ROS levels. [72, 73] The ATM kinase is a kinase which is also involved in UVA damage signalling. [74] The ATM kinase can, via the induction of glucose-6-phosphate dehydrogenase, induce the pentose phosphate pathway. [73, 75] Interestingly, enzymes involved in glycolysis can have additional functions in transcription. The enzyme pyruvate kinase 2 can enhance transcription of glycolytic enzymes. [76] Not only glycolytic enzymes but also the metabolite lactate can modulate transcription as it can act as inhibitor of histone deacetylases, leading to histone hyperacetylation and changes in transcription. [77] In another publication, it was shown that lactate can enhance HIF-1-alpha transcription in human mesenchymal stem cells [78] and higher HIF-1-alpha levels can have impact on glycolysis.
One prerequisite of BER is the accessibility of the DNA, which requires reorganization of chromatin with histone acetylation processes near damaged sites. In this context, DNA damage-mediated histone acetylation can enhance consumption of nuclear acetyl CoA which is in large parts derived from glucose. [79] This process could contribute, at least in a small proportion, to UVA-enhanced glucose consumption. In connection with DNA double-strand break repair, it was shown in tumor cells that glucose starvation decreases DNA repair by interfering with DNA damage-induced histone acetylation (Ampferl et al. 2017).
Other metabolic changes which could occur upon DNA damage (arachidonic acid, urocanic acid, melanin synthesis, polyamine synthesis) [40, 41] do not directly affect glucose metabolism.
The mechanism how UVA radiation enhances glucose consumption and increases production of lactic acid in melanoma cells is not known. What makes this phenomenon more puzzling is that these metabolic changes are lasting far longer (more than 5 days after the last radiation) than the duration of the UVA radiation, indicating a persistent metabolic reprogramming of the melanoma cells, in which the three pathways, Akt kinase, HIF-1-alpha and MAPK could play a role.
| THE AK T K INA S E IS AN IMP ORTANT REG UL ATOR OF G LYCOLYS IS AND SURVIVAL
In the UVA-irradiated melanoma cells, the kinase Akt, which is responsible for metabolic reprogramming and survival, is activated. The activation of Akt can phosphorylate the glucokinase and Bcl2-associated death promoter (BAD) complex, thereby activating glucokinase, promoting glycolysis and inactivating proapoptotic BAD protein. [80, 81] Glucokinase is an isoenzyme of hexokinase (phosphorylating glucose as initial step in glycolysis).
It is usually found in liver cells, but glucokinase activity is also present in melanoma. [82] Furthermore, Akt signalling could activate the expression of glycolytic enzymes. It was shown that Akt activation is sufficient to promote enhanced glycolysis and lactate production. [47, [83] [84] [85] [86] The activation of Akt facilitates the recruitment of the glucose transporter isoform GLUT1 to the cell membrane, [47, 87, 88] and it was shown that the expression of GLUT1 correlated with increased potential for metastasis in melanoma. [89] Taken together, these findings in the literature show that the activation of Akt kinase is a central regulator of glucose consumption and glycolysis. Together with our recent results, showing the UVA-induced glucose consumption is accompanied by activation of Akt, [42] these findings point to Akt as one main candidate facilitating UVA-induced glucose consumption. But these findings do not exclude the contribution of other regulators of UVA-induced glucose metabolism.
| ENHAN CED E XPRE SS I ON AND S TAB ILIZ ATION OF HYP OXIA-INDUCIB LE FAC TOR 1-ALPHA (HIF-1-ALPHA ) S TIMUL ATE S G LYCOLYS IS
Besides Akt, hypoxia-inducible factor 1-alpha (HIF-1-alpha) is another key regulator of glycolysis. HIF-1-alpha is an important cellular sensor of oxygen and ROS and a regulator of respiration. [90] The stabilization of HIF-1-alpha could be another factor accounting for the persistence of UVA-induced glucose consumption. HIF-1-alpha is stabilized by ROS, and this process induces glycolysis and decreases respiration as discussed above. It was reported that UVB radiation stabilized HIF-1-alpha in a ROS-dependent way and increased glycolysis. Not only ROS but also UVA irradiation can increase HIF-1-alpha expression, at least in human fibroblasts, [91] although the HIF-1-alpha expression seems to be higher in UVB-irradiated cells. [92] In addition to this, it was shown that ROS via induction of HIF can promote metabolic reprogramming towards the Warburg effect. [90] The stabilization of HIF-1-alpha enhances glycolysis and glucose consumption via the transcriptional activation of hexokinase, the M2 isoform of pyruvate kinase (PKM2), pyruvate dehydrogenase kinase 1 (PDK1), which inhibits carbon flux into TCA, glucose transporter GLUT1 and GLUT3 and lactate dehydrogenase. [93] Furthermore, HIF activates angiogenesis via VEGF and an increased vascularization of the tumor enhances glucose and oxygen supply of the tumor cells. [80, 94, 95] In UVB-irradiated keratinocytes, a long-term expression of HIF-1-alpha was observed up to 20 hours after radiation. [96] This long-term HIF-1-alpha signalling could also account for the persistent changes in glucose metabolism upon UVA irradiation although this has not been shown for UVA in melanoma cells. It has to be mentioned that AKT and HIF-1-alpha pathways can be closely interconnected. [97, 98] 
| AC TIVATI ON OF MITOG EN -AC TIVATED PROTEIN K INA S E S (MAPK ) S TIMUL ATE S G LYCO LYS I S
As mentioned above, another important cellular reaction upon UVA radiation is the activation of mitogen-activated protein kinases . [100] The MAPK (mitogen-activated protein kinase)-activated protein kinase 2 can be controlled by p38 [101] signalling and is able to activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 phosphofructokinase (PFKFB3), which is an important stimulator of glycolysis. [102, 103] . More studies point to a supporting role of MAPK for glycolysis in tumors; however, in non-tumor liver tissue p38 activation can stimulate gluconeogenesis [104] thereby decreasing glycolysis.
In melanoma, BRAF mutations (V600E) which activate ERK signalling [105] are frequent. Although most of the relevant BRAF mutations in melanoma are not classical UVA fingerprint mutations, they could be derived from genotoxic events induced by UVA irradiation with the involvement of error-prone replication. [20] The activation of the BRAF and ERK pathway can promote glycolysis in melanoma cells. [106] [107] [108] Not much is known about the duration of the UVA-induced MAPK activation, but it can be speculated, that repetitive UVA treatment over several days establishes or enhances a persistent activation of a mitogen-activated protein kinase. Constitutive activation of ERK was already observed in melanoma [109] in which it has been associated with invasion and progression. Taken together, UVA-induced MAPK could contribute to the observed long-term activation of glycolysis and enhanced glucose consumption. The melanoma cells which survive repetitive UVA irradiation could make use of persistent ERK activation as a driver of long-term enhanced glycolysis via transcriptional upregulation of glycolytic enzymes.
| THE ADVANTAG E S OF ENHAN CED G LUCOS E ME TABOLIS M FOR MEL ANOMA
Enhanced glycolysis can supply the cells with pyruvate which can then be metabolized to lactate. We have shown that repetitive UVA irradiation stimulates melanoma cells to secrete large amounts of lactic acid which decreases the pH of the medium. So UVA irradiation enhances glucose consumption and lactate production of the melanoma cells which is already on a high level.
As discussed above, there are several possible starting points for the UVA-enhanced glucose metabolism in melanoma cells, but the important question concerning the benefits of these metabolic changes for the melanoma cell remains.
| ENHAN CED G LUCOS E CON SUMP TI ON IS A SSO CIATED WITH PROLIFER ATING TUMOR S TEM CELL P OPUL ATI ON
In other tumors, subpopulations which harbor high levels of cancer stem cells (CSC), were metabolically analyzed and it was found that they have an increased glucose consumption and an increased glycolysis compared to the remaining tumor cells. [65, 80] Glucose starvation decreased the population of SP while supplementation with glucose increased the population of CSC via the activation of Akt kinase. [65] At least partially the enhanced glucose consumption we observe upon UVA irradiation could be an indicator for proliferation of tumor stem cells in melanoma (Figure 2 ). For the melanoma, an increased population of tumor stem cells would mean better survival rates during treatment and for the patient a higher risk of recurrence after anti-tumor treatments.
| U VA-INDUCED CHANG E S IN G LUCOS E ME TABOLIS M (ENHAN CED G LUCOS E CON SUMP TI ON AND PYRU VATE AND L AC TATE PRODUC TION) PROMOTE INVA S I ON AND IMMUNE E SC APE OF MEL ANOMA CELL S
It has been shown that high levels of lactic acid decrease tumor cell recognition by immune cells and increase anergy or apoptosis of tumor-infiltrating immune cells (Figure 2) . Thus, the immunesuppressing effect of lactate secreted by tumor cells is enhanced by the additional lactate production due to UVA radiation. In detail, lactic acid decreased the production of inflammatory cytokines IL2 and interferon gamma in cytotoxic T cells. [110] Furthermore, high lactic acid concentrations suppress proliferation and the cytotoxic activity of CTL. [110] In these experiments, high lactic acid concentrations suppress the export of lactic acid produced by the T cells, thereby disturbing the metabolism of the T cells. [110] In a mouse melanoma model, tumors with a low lactate level grow slower and have a higher infiltration of cytotoxic effector cells (functionally active CD8 + T cells and NK cells). [111] Contrary to tumor cells, where high lactate concentrations promote migration, [42, 112] monocytes show decreased mobility in the presence of high lactate concentrations. [112] In addition to this, high lactate levels inhibited the secretion of inflammatory cytokines (IL6 and TNF) of monocytes [112] and lactic acid can inhibit activation of dendritic cells. [113] Investigating distribution of tumor-associated macrophages (TAM) in the tumor microenvironment, it was shown that in areas with high lactate concentrations almost no TAM are present. [114] A more detailed study on the effects of lactic acid on macrophages revealed that lactic acidinduced VEGF secretion via HIF-1-alpha [115] and lactic acid increases the population of macrophages with M2 phenotype [115] which promotes tumor growth. [116] A possible interventional approach to decrease UVA-induced lactic acid production and lactic acid promoted immune escape could be the blockade of lactic acid export [117] of melanoma cells.
As it was already shown that the non-steroidal anti-inflammatory drug diclofenac can inhibit lactate export in melanoma cell lines, [118] topical or systemic application of diclofenac or other non-steroidal antiphlogistics could be a potential approach. But further studies are needed in order to verify or falsify this hypothesis.
High lactate levels could not only be toxic to immune cells but also to melanoma cells. One strategy to escape a local high lactate concentration is invasion to peripheral tissue with lower lactate concentrations. It was already known that a low pH or the presence of high lactate levels can promote migration of tumor cells. [112, 119, 120] We could show that either UVA treatment (with increased production of lactic acid) or treatment with lactic acid alone induces the expression of tumor-relevant proteases. [42] These proteases include matrix metalloproteinases (MMP1, MMP2, MMP9 and MMP15) and urokinase-type plasminogen activator (uPA). In particular, MMP2 and MMP9 are involved in progression of melanoma. [121, 122] Interestingly, the enhanced protease expression is accompanied by a decreased transcriptional level of TIMP1, an inhibitor of matrix metalloproteinases, arguing for a coordinated regulation with the objective of extracellular matrix degradation, which is needed for an invasive phenotype of melanoma cells. In accordance with this, the in vitro invasion of an artificial extracellular matrix is increased when melanoma cells are treated with UVA or with lactic acid alone. These data show that there are functional advantages for melanoma cells as lactic acid production also increases invasion (Figure 2 ). It has to be mentioned that UVA irradiation-induced MMP1 secretion by dermal fibroblasts and keratinocytes is also associated with skin ageing, [122, 123] which shows that degradation of extracellular matrix is a necessary but not exclusive phenomenon during melanoma invasion. Interestingly, MMP1 and MMP2 secreted by dermal fibroblasts can support invasion of skin cancers such as basal cell carcinoma and squamous cell carcinoma. [122, 124] 
| AC TIVATED PENTOS E PHOS PHATE PATHWAY WITH NADPH PRODUC TI ON A S ANTI OXIDANT DEFEN CE S TR ATEGY
The ROS as reactive molecules can also harm glycolytic enzymes, therefore decreasing glycolytic activity. The pyruvate kinase PKM2
which is an important glycolytic enzyme in tumor cells can be oxidized in the presence of ROS. Nevertheless, glucose can still be used for another antioxidant defense strategy by employing the pentose phosphate pathway. When glucose is directed to the pentose phosphate pathway NADPH is produced which can be used as an antioxidant, for example, in the glutathione antioxidant system [73, 125, 126] ( Figure 1 ). The function of the pentose phosphate pathway as an important ROS detoxification system is not restricted to humans and is also used in cells of muscle tissue of hawkmoths [127] or in bacteria [128] exposed to oxidative stress conditions. The observation that many proliferating cancer cells have elevated levels of ROS and are dependent on ROS detoxification to avoid large oxidative damage or apoptosis [129] could explain the highly active pentose phosphate pathway in many different tumors. The transcription factor nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) is activated by ROS and facilitates transcription of many key enzymes of the pentose phosphate pathway like transketolase, glucose-6-phosphate dehydrogenase. [73, [130] [131] [132] [133] This system could also be exploited by UVA-irradiated melanoma cells to activate the pentose phosphate pathway via Nrf2 activation. Taken together, these results suggest that one explanation of UVA-induced glucose metabolism could be the need for NADPH as an antioxidative agent ( Figure 2 ). As the pentose phosphate pathway is not only important for many cancers but also for the whole organism, it is difficult to target this metabolic pathway in cancer cells efficiently with systemic treatment and minimal side effects to the patient. But the F I G U R E 1 UVA-induced changes in glucose metabolism and in vitro invasion. UVA irradiation, partially via production of ROS, enhances glucose consumption, lactate production and promotes activation of the pentose phosphate pathway. Lactic acid can promote in vitro invasion and activation of pentose phosphate pathway can provide NADPH for ROS detoxification and riboses for anabolic pathways F I G U R E 2 Potential benefits of UVA-induced changes in glucose metabolism for the melanoma cell. UVA-induced changes in glucose metabolism could have benefits for melanoma proliferation, ROS detoxification, tumor stem cell populations, invasion and immune escape topical treatment to restricted areas of the skin could be an option to interfere with UVA-induced activation of the pentose phosphate pathway in the skin. In a murine model with Ehrlich′s ascitic tumor cells, inhibitors (oxythiamine and dehydroepiandrosterone) of different steps of the pentose phosphate pathway decreased tumor growth. [134, 135] These findings can be useful to develop a selective inhibition of the pentose phosphate pathway as topical therapy on critical areas of sun-exposed skin, which in turn could interfere with UVA-enhanced metabolic changes and the resulting progression of initial melanoma.
| CON CLUS ION
The observation of UVA radiation-induced metabolic changes including increased glucose consumption and lactic acid production as well as activation of the pentose phosphate pathway is a functionally relevant phenomenon in melanoma cells. UVA-induced ROS and stress signalling, as well as Akt kinase signalling, could facilitate these metabolic changes. Interestingly, several advantages can arise from these metabolic changes. The increased production of lactic acid and pyruvate can promote immune escape of melanoma cells and increased production of lactic acid can induce production of tumor-relevant proteases and in vitro invasion. In addition to this, the UVA-induced metabolic changes could be an immediate metabolic strategy (NADPH production) for the detoxification of UVAinduced ROS. The targeting of these metabolic changes with specific inhibitors may be a promising strategy to block UV-induced progression of malignant melanoma.
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